BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Le Ray A, Vert M, Gautier J, Benoǐt J. End‐Chain Radiolabeling and in Vitro Stability Studies of Radiolabeled Poly(hydroxy acid) Nanoparticles. Journal of Pharmaceutical Sciences 1994;83:845-51. [DOI: 10.1002/jps.2600830618] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001;70:1-20. [PMID: 11166403 DOI: 10.1016/s0168-3659(00)00339-4] [Cited by in Crossref: 2283] [Cited by in F6Publishing: 390] [Article Influence: 114.2] [Reference Citation Analysis]
2 Au C, Mutkus L, Dobson A, Riffle J, Lalli J, Aschner M. Effects of nanoparticles on the adhesion and cell viability on astrocytes. Biol Trace Elem Res 2007;120:248-56. [PMID: 17916977 DOI: 10.1007/s12011-007-0067-z] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 4.5] [Reference Citation Analysis]
3 Masson V, Maurin F, Devissaguet J, Fessi H. Stability of poly (ε caprolacton) nanospheres in sterile aqueous media. International Journal of Pharmaceutics 1996;139:113-23. [DOI: 10.1016/0378-5173(96)04611-x] [Cited by in Crossref: 8] [Article Influence: 0.3] [Reference Citation Analysis]
4 Panyam J, Sahoo SK, Prabha S, Bargar T, Labhasetwar V. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles. Int J Pharm 2003;262:1-11. [PMID: 12927382 DOI: 10.1016/s0378-5173(03)00295-3] [Cited by in Crossref: 238] [Cited by in F6Publishing: 49] [Article Influence: 14.0] [Reference Citation Analysis]
5 Le Ray A, Vert M, Gautier J, Benoît J. Fate of [14C]poly(DL-lactide-co-glycolide) nanoparticles after intravenous and oral administration to mice. International Journal of Pharmaceutics 1994;106:201-11. [DOI: 10.1016/0378-5173(94)90003-5] [Cited by in Crossref: 54] [Cited by in F6Publishing: 43] [Article Influence: 2.0] [Reference Citation Analysis]
6 Choubey J, Bajpai AK. Investigation on magnetically controlled delivery of doxorubicin from superparamagnetic nanocarriers of gelatin crosslinked with genipin. J Mater Sci: Mater Med 2010;21:1573-86. [DOI: 10.1007/s10856-010-3997-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
7 Khan H, Shukla R, Bajpai A. Genipin-modified gelatin nanocarriers as swelling controlled drug delivery system for in vitro release of cytarabine. Materials Science and Engineering: C 2016;61:457-65. [DOI: 10.1016/j.msec.2015.12.085] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 7.8] [Reference Citation Analysis]
8 Bajpai AK, Choubey J. In vitro release dynamics of an anticancer drug from swellable gelatin nanoparticles. J Appl Polym Sci 2006;101:2320-32. [DOI: 10.1002/app.23761] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
9 Bajpai AK, Choubey J. Release Study of Sulphamethoxazole Controlled by Swelling of Gelatin Nanoparticles and Drug‐Biopolymer Interaction. Journal of Macromolecular Science, Part A 2005;42:253-75. [DOI: 10.1081/ma-200050357] [Cited by in Crossref: 28] [Article Influence: 1.8] [Reference Citation Analysis]
10 Murthy R, Harivardhan Reddy L. Poly(Alkyl Cyanoacrylate) Nanoparticles for Delivery of Anti-Cancer Drugs. In: Amiji M, editor. Nanotechnology for Cancer Therapy. CRC Press; 2006. pp. 251-88. [DOI: 10.1201/9781420006636.ch15] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
11 Delgado A, Evora C, Llabres M. Degradation of DL-PLA-methadone microspheres during in vitro release. International Journal of Pharmaceutics 1996;140:219-27. [DOI: 10.1016/0378-5173(96)04606-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
12 Bajpai AK, Choubey J. Design of gelatin nanoparticles as swelling controlled delivery system for chloroquine phosphate. J Mater Sci: Mater Med 2006;17:345-58. [DOI: 10.1007/s10856-006-8235-9] [Cited by in Crossref: 85] [Cited by in F6Publishing: 70] [Article Influence: 5.7] [Reference Citation Analysis]
13 Sakuma S, Hayashi M, Akashi M. Design of nanoparticles composed of graft copolymers for oral peptide delivery. Advanced Drug Delivery Reviews 2001;47:21-37. [DOI: 10.1016/s0169-409x(00)00119-8] [Cited by in Crossref: 141] [Cited by in F6Publishing: 13] [Article Influence: 7.1] [Reference Citation Analysis]